Genomics in the era of COVID-19: ethical implications for clinical practice and public health.
Gail GellerPriya DuggalChloe L ThioDebra MathewsJeffrey P KahnLisa L MaragakisBrian T GaribaldiPublished in: Genome medicine (2020)
Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications-both potential benefits and harms-of genomics for clinical practice and public health in the era of COVID-19.